SCOTTSDALE, Ariz., Dec. 27 /PRNewswire-FirstCall/ — MedCom USA, Inc. (OTC Bulletin Board: EMED) announced today that it has filed the SB2 for Card Activation Technologies, Inc. with the SEC.

    MedCom shareholders of record at the close of business on December 15th, 2006 will be issued one share in Card Activation Technologies, Inc. for each share held in MedCom USA, Inc. On that date, there were 86,770,504 shares of MedCom stock outstanding with 44,431,613 shares restricted. The restricted shares issued in Card Activation Technologies, Inc., are being registered under the SB2. MedCom USA has retained 60 million shares of Card Activation Technologies, Inc. stock. The payable date for the stock dividend is to be determined.

    Card Activation Technologies will be filing with the NASD shortly for listing its shares for trading on the Bulletin Board.

    Card Activation Technologies, Inc. is incorporated in Delaware and will focus on the licensing of the proprietary patented payment transaction technology.

    About MedCom USA, Inc.
    MedCom USA, Inc. (OTC Bulletin Board: EMED) provides innovative healthcare and financial transaction solutions for electronically processing HIPAA compliant transactions within the healthcare industry. MedCom USA provides a terminal based service package and a compatible Web Portal add-on for physicians, clinics and hospitals and dentists that include the following services: Real-time transactions including; Patient Eligibility, Referrals, Claims Status and Service Authorizations, 100% Paperless Claims Processing, Patient Easy Pay, Credit/Debit Cards, and Check Guarantee. Visit http://www.medcomusa.com for more information. MedCom USA is the licensor for a patented payment transaction technology.

    Certain matters discussed within this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although MedCom USA, Inc. management believes the expectations reflected in such forward-looking statements are based on reasonable assumptions; it can give no assurance that its expectations will be attained. Factors that could cause actual results to differ materially from expectations include industry, competitive and technological changes; risks associated with international operations and foreign currency fluctuations; the composition, timing and size of orders from and shipments to major customers; inventory obsolescence; market acceptance of new products and other risks detailed from time to time in MedCom USA, Inc.’s SEC reports, including the company’s most recent 10-K and subsequent 10Q-s.